Patient's preferences and shared decision-making: Considering environmental aspects in head lice treatment

被引:1
|
作者
Garcia-Blasco, Camino [1 ]
Domingo-Echaburu, Saioa [2 ]
Orive, Gorka [1 ,3 ,4 ,5 ]
Lertxundi, Unax [6 ]
机构
[1] Univ Basque Country UPV EHU, Sch Pharm, Lab Pharmaceut, NanoBioCel Grp, Paseo Univ 7, Vitoria-Gasteiz 01006, Spain
[2] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Pharm Serv, Nafarroa Hiribidea 16, Arrasate Mondragon 20500, Gipuzkoa, Spain
[3] Biomed Res Networking Ctr Bioengn Biomat & Nanomed, CIBER, BBN, Vitoria-Gasteiz, Spain
[4] Univ Inst Regenerat Med & Oral Implantol, UIRMI UPV EHU, Fdn Eduardo Anitua, Vitoria, Spain
[5] NanoBioCel Res Grp, Bioaraba, Vitoria-Gasteiz, Spain
[6] Araba Psychiat Hosp, Araba Mental Hlth Network, Osakidetza Basque Hlth Serv, Bioaraba Hlth Res Inst,Pharm Serv, c-Alava 43, Vitoria 01006, Alava, Spain
来源
关键词
Permethrin; Head lice; One health; Rational use of medicines;
D O I
10.1016/j.scp.2023.101142
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
One of the most commonly used drugs to treat head lice is permethrin. This drug is also frequently used in veterinary medicine as a pet parasiticide, while its use as a plant protection agent is now restricted because of its ecotoxicity. This substance has been included as a priority substance in the proposal of the European Water Framework Directive and consequently, Environmental Quality Standard (EQS) have been established. Available literature shows that domestic treatment of head lice seems to be the main source of permethrin to municipal wastewater treatment plants (WWTP), while washing pet's hair could also be a contributing factor. Concentration in WWTP effluents are frequently > EQS for different environmental matrices. Besides, studies have shown very high concentrations in sludge, which is worrying considering its use as a fertilizer in agri-culture. The development of resistance of lice to permethrin has driven the development of drugs with different mode of action, such as dimethicone. This drug has shown comparable efficacy to permethrin without its environmental consequences. Moreover, non-pharmacological methods should be preferred when possible. As awareness about the environmental impact of medicines grows, these aspects may become a crucial part of patient's preferences in shared decision-making. Although the ecotoxicological impact of pharmaceuticals is still rarely considered by healthcare professionals or patients when using drugs, the One Health philosophy could also be applied when it comes to treating head lice. We can no longer consider a rational use of medicines if we continue to neglect their environmental impacts.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Patient participation for better shared decision-making
    Steinmeijer, L.
    Van Veenendaal, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S21 - S21
  • [32] Reciprocal acknowledgement and decision-making shared with the patient
    Costa-Alcaraz, A. M.
    Siurana-Aparisi, J. C.
    Almendro-Padilla, C.
    Garcia-Vicente, S.
    Ordovas-Casaurran, R.
    REVISTA CLINICA ESPANOLA, 2011, 211 (11): : 581 - 586
  • [33] Informed Shared Decision-Making and Patient Satisfaction
    Bot, Arjan G. J.
    Bossen, Jeroen K. J.
    Herndon, James H.
    Ruchelsman, David E.
    Ring, David
    Vranceanu, Ana-Maria
    PSYCHOSOMATICS, 2014, 55 (06) : 586 - 594
  • [34] Shared decision-making and the lower literate patient
    Shalowitz, DI
    Wolf, MS
    JOURNAL OF LAW MEDICINE & ETHICS, 2004, 32 (04): : 759 - +
  • [35] Adherence, shared decision-making and patient autonomy
    Sandman, Lars
    Granger, Bradi B.
    Ekman, Inger
    Munthe, Christian
    MEDICINE HEALTH CARE AND PHILOSOPHY, 2012, 15 (02) : 115 - 127
  • [36] Incorporating the Patient Voice Into Shared Decision-Making for the Treatment of Aortic Stenosis
    Lindman, Brian R.
    Perpetua, Elizabeth
    JAMA CARDIOLOGY, 2020, 5 (04) : 380 - 381
  • [37] Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions
    Riggan, Kirsten A.
    Stewart, Elizabeth A.
    Balls-Berry, Joyce E.
    Venable, Sateria
    Allyse, Megan A.
    JOURNAL OF PATIENT EXPERIENCE, 2021, 8
  • [38] Adherence, shared decision-making and patient autonomy
    Lars Sandman
    Bradi B. Granger
    Inger Ekman
    Christian Munthe
    Medicine, Health Care and Philosophy, 2012, 15 : 115 - 127
  • [39] Patient Preferences for Shared Decision Making: Not All Decisions Should Be Shared
    Lindsay, Sarah E.
    Alokozai, Aaron
    Eppler, Sara L.
    Fox, Paige
    Curtin, Catherine
    Gardner, Michael
    Avedian, Raffi
    Palanca, Ariel
    Abrams, Geoffrey D.
    Cheng, Ivan
    Kamal, Robin N.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2020, 28 (10) : 419 - 426
  • [40] Patient Preferences in Treatment Decision-Making at the End of Life: A Qualitative Study
    Brom, Linda
    Pasman, H. Roeline W.
    Widdershoven, Guy A. M.
    van der Vorst, Maurice J.
    Reijneveld, Jaap
    Onwuteaka-Philipsen, Bregje D.
    PSYCHO-ONCOLOGY, 2013, 22 : 7 - 7